Cargando…
Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
Medulloblastoma (MB) is a highly aggressive pediatric tumor of the cerebellum. Hyperactivation of the Hedgehog (HH) pathway is observed in about 30% of all MB diagnoses, thereby bringing out its pharmacological blockade as a promising therapeutic strategy for the clinical management of this malignan...
Autores principales: | Caimano, Miriam, Lospinoso Severini, Ludovica, Loricchio, Elena, Infante, Paola, Di Marcotullio, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215655/ https://www.ncbi.nlm.nih.gov/pubmed/34164380 http://dx.doi.org/10.3389/fchem.2021.688108 |
Ejemplares similares
-
DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer
por: Bufalieri, Francesca, et al.
Publicado: (2020) -
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2019) -
Targeting Hedgehog Signalling through the Ubiquitylation Process: The Multiple Roles of the HECT-E3 Ligase Itch
por: Infante, Paola, et al.
Publicado: (2019) -
The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I
por: Bufalieri, Francesca, et al.
Publicado: (2020) -
Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2022)